DataMEDS AI, Inc. has acquired Helomics Corporation, a cancer diagnostics lab, from Axe Compute Inc. This acquisition will enable DataMEDS to expand its services into cancer management. The move is part of DataMEDS' strategy to enhance its offerings in the healthcare sector. The company aims to leverage Helomics' capabilities to improve cancer treatment and diagnostics.
Company Information
Company
DataMeds AI
Location
Tampa, Florida, United States
About
DataMeds AI, Inc. is a Health IT company focusing on integrating technology, pharmacy, and telemedicine services to improve healthcare experiences. The company utilizes its artificial intelligence platform EinsteinRx™ and blockchain technologies. It aims to facilitate the compliant monetization of health data. DataMeds AI is also known for its subsidiary, Corexa Health, which provides various pharmacy services.
Don't miss DataMeds AI's next move
Get an email the moment DataMeds AI makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for DataMeds AI's next move
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired Helomics Corporation?
Helomics Corporation was acquired by DataMeds AI, based in Tampa. The deal was reported on September 16, 2026. DataMeds AI, Inc. is a Health IT company focusing on integrating technology, pharmacy, and telemedicine services to improve healthcare experiences. DataMeds AI is publicly traded (MEDS) and operates in Information Technology.
When did DataMeds AI acquire Helomics Corporation?
DataMeds AI's acquisition of Helomics Corporation was reported on September 16, 2026. DataMEDS AI, Inc. has acquired Helomics Corporation, a cancer diagnostics lab, from Axe Compute Inc. This acquisition will enable DataMEDS to expand its services into cancer management. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Helomics Corporation do?
Helomics is a functional precision medicine oncology platform that utilizes artificial intelligence to analyze tumor data for drug discovery and treatment decisions. It is known for its innovative approaches in cancer diagnostics. It is privately held, operating in Biotechnology, and is based in Pittsburgh.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.